Evogene Ltd. (EVGN) vs Moolec Science S.A. (MLEC)
A side-by-side comparison of Evogene Ltd. and Moolec Science S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EVGN
Evogene Ltd.
$0.40HealthcareDelayed quote: Oct 6, 2026, 10:53 AM EDT
MLEC
Moolec Science S.A.
$4.68HealthcareDelayed quote: Oct 6, 2026, 10:51 AM EDT
Total return — EVGN vs MLEC
growth of $100 · dividends reinvested · last 6yEVGN -99.3% (-56.4%/yr)MLEC -99.7% (-61.4%/yr)EVGN compounded faster over this window
EVGN MLEC
EVGN vs MLEC: by the numbers
- •EVGN is the larger company ($3M vs $3M market cap).
- •Both run net losses; MLEC's is the smaller (-105.71% vs -694.19% net margin).
Metrics side by side
Valuation
| Metric | EVGN | MLEC |
|---|---|---|
| P/S ratio | 2.65 | N/A |
Profitability
| Metric | EVGN | MLEC |
|---|---|---|
| Gross margin | -6.25% | 34.17% |
| Operating margin | -364.24% | -3.14% |
| Net margin | -694.19% | -105.71% |
| ROE | N/A | -89.85% |
| ROIC | -130.12% | -33.50% |
Growth (annualized)
| Metric | EVGN | MLEC |
|---|---|---|
| Revenue CAGR (5Y) | 2.86% | N/A |
| Total return CAGR (5Y) | -56.46% | -68.13% |
Frequently asked
- How have EVGN and MLEC total returns compared?
- Over the past 5 years, EVGN delivered -56.46% and MLEC delivered -68.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.